返回 Agenda
[V1-S3] Raise the Curtain of “Patient Centricity” in Japan (Part II): Learn by Trial and Error
Session Chair(s)
Norie Miki-Yasuda, PHD
Head of Clinical Operations Europe, Canada, Australia & New Zealand, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
Kaori Muto, PHD
Professor, Department of Public Policy, The Institute of Medical Science, The University of Tokyo, Japan
The idea of Patient Centricity and Patient and Public Engagement are increasingly attracting interest in Japan, while their concept and idea have not been organized among various stakeholders. In this session , pharmaceutical companies will share their activities for patient centricity in clinical trials and discuss Patient Centricity and Patient and Public Engagement together with the speakers of the part 1 session.
Speaker(s)
Andreas Koester, MD, PHD
Vice President and Global Head, Clinical Innovation, Janssen Research & Development, LLC, United States
Innovating with the Patient, for the Patient
Atsushi Kitamura, MS
Clinical Study Innovation Lead, Clinical Operations , Pfizer R&D Japan, Japan
Pharma Company's Patient Centric Activities
Kazuyuki Suzuki, MSC
Feasibility Manager,Devlopment SSO protfolio, Novartis Pharma K.K., Japan
Utilization of Patient Voice to Study Planning
Jin Higashijima, PHD
Associate Professor, Faculty of Global and Science Studies, Yamaguchi University, Japan
Ikuko Yamaguchi
Board Chairperson, NPO COML, Japan